Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- AMBU-B.CO
- Price
- 106.30
- Stock movement up
- +0.40 (0.38%)
- Company name
- Ambu A/S
- Exchange
- (CO ,
- Currency
- DKK )
- Sector
- Healthcare >Medical Devices
- Markedsverdi
- 24.67B
- Ent verdi
- 25.61B
- Pris/omsetning
- 4.58
- Pris/bok
- 4.41
- Utbytte avkastning
- -
- Utbytte vekst
- -
- Vekst år
- -
- FCF-utbetaling
- -
- Etterfølgende P/E
- 104.97
- Fremtidig P/E
- 43.39
- PEG
- -
- EPS-vekst
- -7.23%
- 1 års avkastning
- 2.41%
- 3 års avkastning
- -12.99%
- 5 års avkastning
- -0.66%
- 10 års avkastning
- 17.68%
Sist oppdatert: 2024-12-21
UTBYTTE
AMBU-B.CO betaler ikke utbytte
VERDSETTELSE
Verdsettelsesforhold
Loading...
Verdsettelsesforhold-data
| Etterfølgende P/E | 104.97 |
| Pris til OCF | 30.34 |
| Pris til FCF | 42.24 |
| Pris til EBITDA | 47.62 |
| EV i forhold til EBITDA | 49.45 |
Verdsettelse (Salg/Bokført verdi)
Loading...
Verdsettelse (Salg/Bokført verdi) data
| Pris til omsetning | 4.58 |
| Pris til bok | 4.41 |
| EV i forhold til salg | 4.75 |
ØKONOMI
Per aksje
Loading...
Per aksje-data
| Gjeldende aksje antall | 232.07M |
| EPS (TTM) | 0.89 |
| FCF per aksje (TTM) | 2.21 |
Resultatregnskap
Loading...
Resultatregnskap-data
| Inntekter (TTM) | 5.39B |
| Bruttofortjeneste (TTM) | 3.20B |
| Driftsinntekter (TTM) | 311.00M |
| Netto inntekt (TTM) | 235.00M |
| EPS (TTM) | 0.89 |
| EPS (1 år fremover) | 2.45 |
Marginer
Loading...
Marginer-data
| Bruttomargin (TTM) | 59.38% |
| Driftsmargin (TTM) | 5.77% |
| Fortjenestemargin (TTM) | 4.36% |
Balanse
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Balanse-data
| Kontanter | 615.00M |
| Netto fordringer | 829.00M |
| Samlede omløpsmidler | 2.64B |
| Goodwill | 1.53B |
| Immaterielle eiendeler | 1.70B |
| Eiendom, anlegg og utstyr | 0.00 |
| Sum eiendeler | 7.15B |
| Leverandørgjeld | 490.00M |
| Kortsiktig/nåværende langsiktig gjeld | 558.00M |
| Sum kortsiktig gjeld | 1.06B |
| Sum gjeld | 1.56B |
| Aksjonærenes egenkapital | 5.59B |
| Netto varige driftsmidler | 0.00 |
Kontantstrøm
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Kontantstrøm-data
| Kontantstrøm fra drift (TTM) | 813.00M |
| Kapitalutgifter (TTM) | 229.00M |
| Fri kontantstrøm (TTM) | 584.00M |
| Utbetalt utbytte (TTM) | 0.00 |
Finansielle inntekter
Loading...
Opprett en gratis konto eller logg inn for å få tilgang til dette diagrammet
Finansielle inntekter-data
| Egenkapitalavkastning | 4.20% |
| Avkastning på eiendeler | 3.28% |
| Avkastning på investert kapital | 4.15% |
| Kontantavkastning på investert kapital | 10.30% |
AKSJEINFORMASJON
Aksjediagram
Loading...
Aksjekurs-data
| Åpning | 105.50 |
| Daglig høy | 106.55 |
| Daglig lav | 103.85 |
| Daglig volum | 517K |
| Tidenes høyeste | 355.40 |
| 1 år analytikerestimat | 127.63 |
| Beta | 0.79 |
| EPS (TTM) | 0.89 |
| Utbytte per aksje | - |
| Ex-div dato | 5 Dec 2024 |
| Neste dato for resultatpresentasjon | 30 Jan 2025 |
Nedsidepotensial
Loading...
Nedsidepotensial-data
| AMBU-B.CO | S&P500 | |
| Nåværende prisfall fra toppnotering | -70.09% | -2.74% |
| Høyeste prisfall | -82.62% | -56.47% |
| Dato for høyeste fall | 22 Sep 2022 | 9 Mar 2009 |
| Gj.snittlig fall fra topp | -31.82% | -11.13% |
| Gj.snittlig tid til ny topp | 24 days | 12 days |
| Maks tid til ny topp | 1367 days | 1805 days |
SELSKAPSOPPLYSNINGER
Markedsverdi
24.67B
Markedsverdi kategori
Large-cap
Beskrivelse
Ambu A/S, a medical technology company, develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, and displaying units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products; airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, resuscitators, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.
Ansatte
5196
Nettsted
Investorrelasjoner
-
SEC-innsendelser
Adm. direktør
Land
Denmark
By
Aksjetype
-
CCC-status
-
Utbyttefrekvens
-
ARRANGEMENTER OG PRESENTASJONER
ArrangementerPresentasjoner
Loading...
FORSTÅ VIRKSOMHETEN
Loading...
NYHETER OM SELSKAPET
Alle nyheterPressemeldinger
In the wake of recent U.S. election results and a subsequent rally in major stock indices, global markets are witnessing heightened investor optimism fueled by expectations of economic growth and regu...
14. november 2024
As global markets continue to navigate a complex economic landscape, U.S. stocks have reached new highs, buoyed by a promising start to the earnings season despite some inflationary pressures and mixe...
16. oktober 2024
Amid recent market turbulence, with the S&P 500 Index experiencing its steepest weekly drop in 18 months due to economic slowdown concerns, investors are seeking stability and growth. In this environm...
12. september 2024
As global markets continue to navigate volatility driven by economic growth concerns and technical factors, investors are increasingly seeking stability and potential upside in their portfolios. One s...
13. august 2024
As global markets show signs of resilience, with indices like the Russell 2000 Index witnessing notable gains amidst fluctuating economic indicators, investors are keenly watching for opportunities th...
15. juli 2024
As global markets navigate through a landscape of mixed economic signals and fluctuating indices, investors are closely monitoring trends that could influence their portfolios. Amidst this backdrop, g...
13. juni 2024
As global markets show signs of resilience with indices like the S&P 500 nearing record highs and the UK economy emerging from recession, investors are closely monitoring shifts in market dynamics and...
15. mai 2024
Pursuant to Ambu A/S’ (Ambu) Remuneration Policy, a total of 172,956 Performance Share Units (PSUs) related to Ambu’s long-term incentive programme (LTIP) for 2023/24 have been granted on 6 February 2...
6. februar 2024
In Q1 2023/24, Ambu delivered 14% organic revenue growth and a 10.0% EBIT margin before special items. This was driven by Endoscopy Solutions growing 25%, due to continued high double-digit growth wit...
30. januar 2024